GlassScriptPhysician profile
Latasha Kaye Steele
NPI 1801151147
$2,954.64
in general payments reported to CMS, 2019-2025
27 companies · $464 in 2025
The $464 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $206 · 2021: $254 · 2022: $581 · 2023: $730 · 2024: $508 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,701.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $359.77 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $346.18 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $214.26 | 2020-2025 | Myosure Tissue Removal Device, Novasure, Fluent Fluid Management System |
| Evofem Biosciences, INC. | $188.10 | 2023-2025 | Phexxi, Solosec, Phexx |
| Biogen, INC. | $183.26 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $175.08 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $145.83 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $139.61 | 2022-2024 | |
| Medtronic, INC. | $135.59 | 2021-2024 | Truclear, Venaseal |
| Coopersurgical, INC. | $132.30 | 2020-2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $128.33 | 2020-2023 | |
| Pfizer INC. | $126.18 | 2021-2024 | |
| Organon LLC | $99.87 | 2022-2025 | Nexplanon |
| Acessa Health INC. | $96.90 | 2019 | |
| Exeltis, USA INC. | $90.32 | 2020-2025 | Slynd |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $61.90 | 2020-2023 | Divigel |
| Optumhealth Care Solutions, LLC | $53.81 | 2023-2024 | Zyno Solutions, Vivify Health Care Team Portal, Vivify Health Care Team Portal 001 |
| Aspira Women'S Health INC | $45.67 | 2022-2024 | Ova1 |
| Covidien LP | $43.73 | 2020 | |
| Dexcom, INC. | $35.60 | 2025 | Dexcom G6 Transmitter |
| Gynesonics, INC. | $30.14 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Innovation Technologies INC | $26.71 | 2024 | Irrisept |
| Medicem INC. | $26.51 | 2020-2021 | |
| Agile Therapeutics, INC. | $19.65 | 2022 | |
| Mylan Pharmaceuticals INC. | $17.68 | 2022 | |
| Lupin INC. | $16.61 | 2020 | |
| Bolder Surgical, LLC | $15.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latasha Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.